IL-1 beta Human ELISA Kit, Ultrasensitive
IL-1 beta Human ELISA Kit, Ultrasensitive
Invitrogen™

IL-1 beta Human ELISA Kit, Ultrasensitive

The Human IL-1β Ultrasensitive ELISA Kit quantifies natural and recombinant Hu IL-1β in human serum, EDTA plasma, buffered solution, orRead more
Have Questions?
Catalog NumberQuantity
KHC001496 Tests
Catalog number KHC0014
Price (CLP)
-
Quantity:
96 Tests
The Human IL-1β Ultrasensitive ELISA Kit quantifies natural and recombinant Hu IL-1β in human serum, EDTA plasma, buffered solution, or cell culture medium. Interleukin-1β (IL-1β) is important in immune response.
For Research Use Only. Not for use in diagnostic procedures.
Specifications
Assay Range0.31-20 pg/mL
Assay Sensitivity<0.06 pg/mL
For Use With (Equipment)Microplate Reader
Former IdentifiersNovex
Geneinterleukin 1 beta
Gene AliasIL-1, IL1-BETA, IL1F2
Gene ID (Entrez)3553
Gene SymbolIL1B
Immunoassay Kit GradeUltrasensitive
Incubation Time5 hr
Label or DyeHRP
ProteinInterleukin-1 beta
Protein AliasesIL-1 beta, Catabolin
Protein FamilyCytokines & Receptors
Quantity96 Tests
Sample Volume100 μL
Shipping ConditionWet Ice
Target Kit NamedIL-1 beta
Target Species ValidatedHuman
UniProt IDP01584
Detection MethodColorimetric
Immunoassay Kit FormatCoated ELISA Kit
Sample TypeCell Culture Supernatant, Plasma, Serum
Target SpeciesHuman
Unit Size96 tests
Contents & Storage
Pre-coated plate(s), standard or calibrator, detector antibody, HRP conjugate, diluents, wash buffer, substrate(s), and stop solution. Store kit at 2-8°C. See product manual for detailed contents and storage conditions for maximum stability.

Frequently asked questions (FAQs)

Does the Human IL-1 beta Ultrasensitive ELISA Kit (Cat. No. KHC0014) use the same antibodies as the Human IL-1 beta ELISA Kit (Cat. No. KHC0011)?

No, the kits use different antibodies.

Find additional tips, troubleshooting help, and resources within our Antibodies and Immunoassays Support Center.

Will ProcartaPlex multiplex assays give me the same results for each analyte as my current ELISA tests?

ProcartaPlex multiplex assays, which are based on Luminex xMAP technology, provide a versatile platform that gives users more flexibility and a greater array of options for analyte detection. Whether you are testing for single or multiple analytes, ProcartaPlex multiplex assays deliver accurate analytical performance using efficient, easy-to-follow protocols. Each of these assays has undergone the same development, validation, manufacturing, and quality control standardization we conduct for our ELISAs. Each lot of ProcartaPlex multiplex assays as well as ELISA assays is fully qualified with the appropriate sample type (i.e., species-specific serum, plasma, and cell culture supernatants), and each lot is evaluated based on the following performance characteristics:

Specificity-each analyte is screened to make sure there is no significant cross-reactivity with other analytes in the multiplex test
Sensitivity-each analyte is evaluated for both functional sensitivity (differentiation from background) and lower limit of detection (LLOD)
Precision/accuracy-multiplex assays have good intra-assay precision (<10% CV), inter-assay precision (<10% CV), and lot-to-lot consistency (<20% CV); these values are comparable to or better than most ELISA tests
ProcartaPlex multiplex assays are regularly tested against the matching ELISAs. Therefore, you can switch easily from ProcartaPlex assays to ELISA and vice versa with reliable results. Most of our ProcartaPlex assays use the same antibody pairs as our traditional plate-based ELISAs, resulting in high correlation (R2 > 0.9) between the two assays.

Find additional tips, troubleshooting help, and resources within our Antibodies and Immunoassays Support Center.

Why should I consider switching from ELISA technology to multiplexing?

ELISA is a simple and powerful way to quantify individual proteins specifically in complex samples. The selectivity of ELISA is achieved through the use of qualified single- or double-antibody sandwich technology, and accurate quantitation is achieved through the use of calibrated standards. ELISAs can detect low-level proteins and can be performed in a 96-well format with only 60 minutes of hands-on time. In addition, the results obtained with ELISAs are generally very reproducible. While ELISA has been established as a standard method of protein analysis, multiplexing methods that enable the measurement of multiple analytes simultaneously in a single sample address a number of specific limitations:

ELISA allows for the measurement of only one analyte at a time in a given sample, limiting investigators' increasing need to measure multiple targets in their research studies.
The low available volume of many samples being studied may limit the number of times analyses can be conducted. This is especially true in small animal research, in pediatric testing, and in microplate assays providing limited sample volumes. The ability to assay multiple analytes in a single small-volume sample enables more effective use of each sample.
Difficulties in data interpretation can arise when comparing analyte levels measured by multiple ELISAs, each assay having been performed with different sample aliquots and each susceptible to systematic errors leading to decreased precision and accuracy.
Many analytes require assays with broad dynamic ranges to avoid repeat testing or out-of-range values. Multiplex assays can be designed to have large dynamic ranges for all of the analytes, or ranges tailored to various expected analyte concentrations.

Find additional tips, troubleshooting help, and resources within our Antibodies and Immunoassays Support Center.

I performed an ELISA assay, and the A450 readings for my duplicate wells were very inconsistent. What could have gone wrong?

Here are possible causes and solutions:

Errors in pipetting the standards or samples or in subsequent steps. Always dispense into wells quickly and in the same order. Do not touch the pipette tip on the individual microwells when dispensing. Use calibrated pipettes and the appropriate tips for that device. Check for any leaks in the pipette tip.
Repetitive use of tips for several samples or different reagents. Use fresh tips for each sample or reagent transfer.
Wells have been scratched with the pipette tip or washing tips. Use caution when dispensing into and aspirating out of microwells.
Liquid transferred from well to well during incubations. Adjust the orbital shaker or check for correct rotator rpm. Peel the adhesive plate cover off carefully.
Incorrect volumes of materials dispensed into the microwells. Follow the protocol for dispensing volumes of reagents. Check calibration of the pipettes.
Standard diluted with the serum, culture medium, or other buffer. Dilute the standard with the standard diluent buffer provided in the kit.
Particulates or precipitates present in the samples. Remove any particulates/precipitates by centrifugation prior to dispensing into the assay.
Dirty microwells: visible debris within or on bottom of microwells. Inspect the microwells and invert the plate to remove debris. Wipe the bottom of the plate with an absorbent tissue after each wash step. Never insert tissue into the microwells.
“Edge effect” due to uneven temperature between the outer-edge wells and the wells in the center of the plate. Seal the plate completely with a cover during incubations, and place the plate in the center of the incubator when 37 degrees C incubation is indicated.

Find additional tips, troubleshooting help, and resources within our Antibodies and Immunoassays Support Center.

I got a poor standard curve after my ELISA. Why is this?

Here are possible causes and solutions:

Improper preparation of standard stock solution.Dilute the lyophilized standard as directed on the vial label, only with the standard diluent buffer or a diluent that most closely matches the matrix of your sample.
Reagents (lyophilized standard, standard diluent buffer, etc.) from different kits, with either different analytes or different lot numbers, were substituted. Never substitute any components from another kit.
Errors in pipetting the standard or in subsequent steps. Always dispense into wells quickly and in the same order. Do not touch the pipette tips on the individual microwells when dispensing. Use calibrated pipettes and the appropriate tips for that device.

Find additional tips, troubleshooting help, and resources within our Antibodies and Immunoassays Support Center.

Citations & References (4)

Citations & References
Abstract
Calprotectin in gingival crevicular fluid correlates with clinical and biochemical markers of periodontal disease.
Authors:Kido J, Nakamura T, Kido R, Ohishi K, Yamauchi N, Kataoka M, Nagata T,
Journal:J Clin Periodontol
PubMed ID:10522776
'Clinical and biochemical markers of periodontal disease have been used for precise objective diagnosis of periodontal inflammation. Interleukin 1beta (IL-1beta) and prostaglandin E2 (PGE2), inflammatory factors, levels in gingival crevicular fluid (GCF) of patients with periodontal disease are elevated and have been studied as biochemical markers. The levels of calprotectin, ... More
Clinical efficacy of intravenous immunoglobulin for patients with MPO-ANCA-associated rapidly progressive glomerulonephritis.
Authors:Ito-Ihara T, Ono T, Nogaki F, Suyama K, Tanaka M, Yonemoto S, Fukatsu A, Kita T, Suzuki K, Muso E,
Journal:Nephron Clin Pract
PubMed ID:16174989
'To determine whether intravenous immunoglobulin (IVIg) can control disease activity in patients with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA)-associated rapidly progressive glomerulonephritis (RPGN). Twelve patients with serologically and histologically confirmed MPO-ANCA-associated RPGN (7 men, 5 women; mean age 71 +/- 3 years) received IVIg (400 mg/kg/day) alone for 5 days. The effects ... More
Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.
Authors:Ueland T, Fougner SL, Godang K, Lekva T, Schurgers LJ, Scholz H, Halvorsen B, Schreiner T, Aukrust P, Bollerslev J
Journal:J Clin Endocrinol Metab
PubMed ID:19880791
Patients with active acromegaly display a range of abnormalities in glucose metabolism. To elucidate interactions between bone and energy homeostasis in relation to excess GH, we sought to determine whether these patients were characterized by alterations in circulating levels of adipokines and cytokines and potential interactions with osteocalcin (OCN) and ... More
Remote ischemic preconditioning regulates HIF-1a levels, apoptosis and inflammation in heart tissue of cardiosurgical patients: a pilot experimental study.
Authors:Albrecht M, Zitta K, Bein B, Wennemuth G, Broch O, Renner J, Schuett T, Lauer F, Maahs D, Hummitzsch L, Cremer J, Zacharowski K, Meybohm P,
Journal:Basic Res Cardiol
PubMed ID:23203207
Transient episodes of ischemia in a remote organ (remote ischemic preconditioning, RIPC) bears the potential to attenuate myocardial injury, but the underlying mechanisms are only poorly understood. In the pilot experimental study presented we investigated cellular and molecular effects of RIPC in heart tissue of cardiosurgical patients with cardiopulmonary bypass ... More